Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Flamini JR"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sankar R; Departments of Neurology and Pediatrics, David Geffen School of Medicine at UCLA, University of California, Los Angeles, CA, USA; UCLA Mattel Children's Hospital, Los Angeles, CA, USA. Electronic address: RSankar@ucla.edu., Chez M; Sutter Health, Roseville, CA, USA; California Northstate University School of Medicine, Elk Grove, CA, USA., Pina-Garza JE; The Children's Hospital at TriStar Centennial, Nashville, TN, USA., Dixon-Salazar T; Lennox-Gastaut Syndrome Foundation, San Diego, CA, USA., Flamini JR; PANDA Neurology, Atlanta, GA, USA., Hyslop A; Stanford University School of Medicine, Palo Alto, CA, USA., McGoldrick P; Boston Children's Health Physicians, Valhalla, NY, USA; Maria Fareri Children's Hospital, Valhalla, NY, USA; New York Medical College, Valhalla, NY, USA., Millichap JJ; Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Resnick T; Nicklaus Children's Hospital, Miami, FL, USA., Rho JM; Departments of Neurosciences, Pediatrics & Pharmacology, University of California San Diego and Rady Children's Hospital, San Diego, CA, USA., Wolf S; Boston Children's Health Physicians, Valhalla, NY, USA; Maria Fareri Children's Hospital, Valhalla, NY, USA; New York Medical College, Valhalla, NY, USA.
Publikováno v:
Seizure [Seizure] 2023 Aug; Vol. 110, pp. 42-57. Date of Electronic Publication: 2023 May 25.
Autor:
Park YD; Augusta University, Augusta, GA, United States. Electronic address: YPARK@augusta.edu., Linder DF; Augusta University, Augusta, GA, United States. Electronic address: dlinder@augusta.edu., Pope J; Augusta University, Augusta, GA, United States. Electronic address: jampope@umd.edu., Flamini JR; Panda Neurology, Atlanta, GA, United States. Electronic address: rflamini@comcast.net., Moretz K; Memorial Health University Medical Center, Savannah, GA, United States., Diamond MP; Augusta University, Augusta, GA, United States. Electronic address: midiamond@augusta.edu., Long SA; Augusta University, Augusta, GA, United States. Electronic address: salong@augusta.edu.
Publikováno v:
Epilepsy & behavior : E&B [Epilepsy Behav] 2020 Nov; Vol. 112, pp. 107474. Date of Electronic Publication: 2020 Sep 28.
Autor:
Farkas V; From the First Department of Pediatrics (V.F.), Semmelweis University, Budapest, Hungary; Department of Developmental Neurology (B.S.), Poznań University of Medical Sciences, Poland; PANDA Neurology (J.R.F.), Atlanta, GA; UCB Pharma (Y.Z., N.Y., A.B., T.D.), Raleigh, NC; UCB Pharma (S.B.), Slough, UK; UCB Pharma (P.M.), Braine-l'Alleud, Belgium; Evidence Scientific Solutions (H.C.C.), Horsham, UK; UCB Pharma (S.D.), Brussels, Belgium; and Austin Health (I.E.S.), Florey and Murdoch Children's Research Institute, University of Melbourne, Australia. farkas.viktor@med.semmelweis-univ.hu., Steinborn B; From the First Department of Pediatrics (V.F.), Semmelweis University, Budapest, Hungary; Department of Developmental Neurology (B.S.), Poznań University of Medical Sciences, Poland; PANDA Neurology (J.R.F.), Atlanta, GA; UCB Pharma (Y.Z., N.Y., A.B., T.D.), Raleigh, NC; UCB Pharma (S.B.), Slough, UK; UCB Pharma (P.M.), Braine-l'Alleud, Belgium; Evidence Scientific Solutions (H.C.C.), Horsham, UK; UCB Pharma (S.D.), Brussels, Belgium; and Austin Health (I.E.S.), Florey and Murdoch Children's Research Institute, University of Melbourne, Australia., Flamini JR; From the First Department of Pediatrics (V.F.), Semmelweis University, Budapest, Hungary; Department of Developmental Neurology (B.S.), Poznań University of Medical Sciences, Poland; PANDA Neurology (J.R.F.), Atlanta, GA; UCB Pharma (Y.Z., N.Y., A.B., T.D.), Raleigh, NC; UCB Pharma (S.B.), Slough, UK; UCB Pharma (P.M.), Braine-l'Alleud, Belgium; Evidence Scientific Solutions (H.C.C.), Horsham, UK; UCB Pharma (S.D.), Brussels, Belgium; and Austin Health (I.E.S.), Florey and Murdoch Children's Research Institute, University of Melbourne, Australia., Zhang Y; From the First Department of Pediatrics (V.F.), Semmelweis University, Budapest, Hungary; Department of Developmental Neurology (B.S.), Poznań University of Medical Sciences, Poland; PANDA Neurology (J.R.F.), Atlanta, GA; UCB Pharma (Y.Z., N.Y., A.B., T.D.), Raleigh, NC; UCB Pharma (S.B.), Slough, UK; UCB Pharma (P.M.), Braine-l'Alleud, Belgium; Evidence Scientific Solutions (H.C.C.), Horsham, UK; UCB Pharma (S.D.), Brussels, Belgium; and Austin Health (I.E.S.), Florey and Murdoch Children's Research Institute, University of Melbourne, Australia., Yuen N; From the First Department of Pediatrics (V.F.), Semmelweis University, Budapest, Hungary; Department of Developmental Neurology (B.S.), Poznań University of Medical Sciences, Poland; PANDA Neurology (J.R.F.), Atlanta, GA; UCB Pharma (Y.Z., N.Y., A.B., T.D.), Raleigh, NC; UCB Pharma (S.B.), Slough, UK; UCB Pharma (P.M.), Braine-l'Alleud, Belgium; Evidence Scientific Solutions (H.C.C.), Horsham, UK; UCB Pharma (S.D.), Brussels, Belgium; and Austin Health (I.E.S.), Florey and Murdoch Children's Research Institute, University of Melbourne, Australia., Borghs S; From the First Department of Pediatrics (V.F.), Semmelweis University, Budapest, Hungary; Department of Developmental Neurology (B.S.), Poznań University of Medical Sciences, Poland; PANDA Neurology (J.R.F.), Atlanta, GA; UCB Pharma (Y.Z., N.Y., A.B., T.D.), Raleigh, NC; UCB Pharma (S.B.), Slough, UK; UCB Pharma (P.M.), Braine-l'Alleud, Belgium; Evidence Scientific Solutions (H.C.C.), Horsham, UK; UCB Pharma (S.D.), Brussels, Belgium; and Austin Health (I.E.S.), Florey and Murdoch Children's Research Institute, University of Melbourne, Australia., Bozorg A; From the First Department of Pediatrics (V.F.), Semmelweis University, Budapest, Hungary; Department of Developmental Neurology (B.S.), Poznań University of Medical Sciences, Poland; PANDA Neurology (J.R.F.), Atlanta, GA; UCB Pharma (Y.Z., N.Y., A.B., T.D.), Raleigh, NC; UCB Pharma (S.B.), Slough, UK; UCB Pharma (P.M.), Braine-l'Alleud, Belgium; Evidence Scientific Solutions (H.C.C.), Horsham, UK; UCB Pharma (S.D.), Brussels, Belgium; and Austin Health (I.E.S.), Florey and Murdoch Children's Research Institute, University of Melbourne, Australia., Daniels T; From the First Department of Pediatrics (V.F.), Semmelweis University, Budapest, Hungary; Department of Developmental Neurology (B.S.), Poznań University of Medical Sciences, Poland; PANDA Neurology (J.R.F.), Atlanta, GA; UCB Pharma (Y.Z., N.Y., A.B., T.D.), Raleigh, NC; UCB Pharma (S.B.), Slough, UK; UCB Pharma (P.M.), Braine-l'Alleud, Belgium; Evidence Scientific Solutions (H.C.C.), Horsham, UK; UCB Pharma (S.D.), Brussels, Belgium; and Austin Health (I.E.S.), Florey and Murdoch Children's Research Institute, University of Melbourne, Australia., Martin P; From the First Department of Pediatrics (V.F.), Semmelweis University, Budapest, Hungary; Department of Developmental Neurology (B.S.), Poznań University of Medical Sciences, Poland; PANDA Neurology (J.R.F.), Atlanta, GA; UCB Pharma (Y.Z., N.Y., A.B., T.D.), Raleigh, NC; UCB Pharma (S.B.), Slough, UK; UCB Pharma (P.M.), Braine-l'Alleud, Belgium; Evidence Scientific Solutions (H.C.C.), Horsham, UK; UCB Pharma (S.D.), Brussels, Belgium; and Austin Health (I.E.S.), Florey and Murdoch Children's Research Institute, University of Melbourne, Australia., Carney HC; From the First Department of Pediatrics (V.F.), Semmelweis University, Budapest, Hungary; Department of Developmental Neurology (B.S.), Poznań University of Medical Sciences, Poland; PANDA Neurology (J.R.F.), Atlanta, GA; UCB Pharma (Y.Z., N.Y., A.B., T.D.), Raleigh, NC; UCB Pharma (S.B.), Slough, UK; UCB Pharma (P.M.), Braine-l'Alleud, Belgium; Evidence Scientific Solutions (H.C.C.), Horsham, UK; UCB Pharma (S.D.), Brussels, Belgium; and Austin Health (I.E.S.), Florey and Murdoch Children's Research Institute, University of Melbourne, Australia., Dimova S; From the First Department of Pediatrics (V.F.), Semmelweis University, Budapest, Hungary; Department of Developmental Neurology (B.S.), Poznań University of Medical Sciences, Poland; PANDA Neurology (J.R.F.), Atlanta, GA; UCB Pharma (Y.Z., N.Y., A.B., T.D.), Raleigh, NC; UCB Pharma (S.B.), Slough, UK; UCB Pharma (P.M.), Braine-l'Alleud, Belgium; Evidence Scientific Solutions (H.C.C.), Horsham, UK; UCB Pharma (S.D.), Brussels, Belgium; and Austin Health (I.E.S.), Florey and Murdoch Children's Research Institute, University of Melbourne, Australia., Scheffer IE; From the First Department of Pediatrics (V.F.), Semmelweis University, Budapest, Hungary; Department of Developmental Neurology (B.S.), Poznań University of Medical Sciences, Poland; PANDA Neurology (J.R.F.), Atlanta, GA; UCB Pharma (Y.Z., N.Y., A.B., T.D.), Raleigh, NC; UCB Pharma (S.B.), Slough, UK; UCB Pharma (P.M.), Braine-l'Alleud, Belgium; Evidence Scientific Solutions (H.C.C.), Horsham, UK; UCB Pharma (S.D.), Brussels, Belgium; and Austin Health (I.E.S.), Florey and Murdoch Children's Research Institute, University of Melbourne, Australia.
Publikováno v:
Neurology [Neurology] 2019 Sep 17; Vol. 93 (12), pp. e1212-e1226. Date of Electronic Publication: 2019 Aug 28.
Autor:
Franz DN; Department of Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States of America., Belousova E; Department of Pediatrics, Research and Clinical Institute of Pediatrics, Pirogov Russian National Research Medical University, Moscow, Russia., Sparagana S; Department of Neurology, Texas Scottish Rite Hospital for Children, Dallas, Texas, United States of America., Bebin EM; Department of Neurology, University of Alabama School of Medicine, Birmingham, Alabama, United States of America., Frost MD; Department of Neurology, Minnesota Epilepsy Group, St. Paul, Minnesota, United States of America., Kuperman R; Department of Neurology, Children's Hospital and Research Center, Oakland, California, United States of America., Witt O; Department of Oncology, University of Heidelberg Medical Center and German Cancer Research Center, Heidelberg, Germany., Kohrman MH; Department of Neurology, University of Chicago, Chicago, Illinois, United States of America., Flamini JR; Department of Neurology, Children's Healthcare of Atlanta, Atlanta, Georgia, United States of America., Wu JY; Department of Neurology, Mattel Children's Hospital at the University of California Los Angeles, Los Angeles, California, United States of America., Curatolo P; Department of Neurology, University of Rome Tor Vergata, Rome, Italy., de Vries PJ; Department of Psychiatry and Mental Health, Division of Child & Adolescent Psychiatry, University of Cape Town, Cape Town, South Africa., Berkowitz N; Department of Oncology, Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, United States of America., Niolat J; Department of Oncology, Novartis Pharmaceuticals S.A.S., Rueil-Malmaison, France., Jóźwiak S; Department of Pediatric Neurology, Medical University of Warsaw, Warsaw, Poland.
Publikováno v:
PloS one [PLoS One] 2016 Jun 28; Vol. 11 (6), pp. e0158476. Date of Electronic Publication: 2016 Jun 28 (Print Publication: 2016).
Autor:
Franz DN; Department of Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. Electronic address: david.franz@cchmc.org., Belousova E; Moscow Research Institute of Pediatrics and Pediatric Surgery, Moscow, Russia., Sparagana S; Department of Neurology, Texas Scottish Rite Hospital for Children, Dallas, TX, USA., Bebin EM; Department of Neurology, University of Alabama School of Medicine, Birmingham, AL, USA., Frost M; Department of Neurology, Minnesota Epilepsy Group, St Paul, MN, USA., Kuperman R; Department of Neurology, Children's Hospital and Research Center, Oakland, CA, USA., Witt O; Department of Oncology, University of Heidelberg Medical Center and German Cancer Research Center, Heidelberg, Germany., Kohrman MH; Department of Neurology, University of Chicago, Chicago, IL, USA., Flamini JR; Department of Neurology, Children's Healthcare of Atlanta, Atlanta, GA, USA., Wu JY; Department of Neurology, Mattel Children's Hospital, University of California, Los Angeles, Los Angeles, CA, USA., Curatolo P; Department of Neurology, University of Rome Tor Vergata, Rome, Italy., de Vries PJ; Department of Psychiatry and Mental Health, Division of Child and Adolescent Psychiatry, University of Cape Town, South Africa., Berkowitz N; Department of Oncology, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Anak O; Department of Oncology, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Niolat J; Novartis Pharmaceuticals SAS, Rueil-Malmaison, France., Jozwiak S; Department of Neurology, Children's Memorial Health Institute, Al Dzieci Polskich 20, Warsaw, Poland.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2014 Dec; Vol. 15 (13), pp. 1513-1520. Date of Electronic Publication: 2014 Nov 10.